Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2017Frontiers in ImmunologyOpen Access

Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJialin SongYOYuanming OuyangJCJunyi Che

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Song et al. (2017) studied this question.

synapsesocial.com/papers/6a739d53377577bf844c9d64https://doi.org/10.3389/fimmu.2017.00056
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MicroRNA‐221 promotes colorectal cancer cell invasion and metastasis by targeting RECK2013 · 89 citations
  2. 2miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status2014 · 97 citations
  3. 3miR-221 overexpression contributes to liver tumorigenesis2009 · 696 citations
  4. 4miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer2014 · 82 citations
  5. 5Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells2015 · 49 citations